Role of implantable cardioverter defibrillators in the treatment of hypertrophic cardiomyopathy

Ghosh, Joydeep; Francis, Johnson and Maron, Barry J. (2005) Role of implantable cardioverter defibrillators in the treatment of hypertrophic cardiomyopathy. Indian Pacing and Electrophysiology Journal, 5 (2). pp. 72-75. ISSN 0972-6292

Full text available as:

PDF - Requires Adobe Acrobat Reader or other PDF viewer.
125 Kb
25 Kb


Hypertrophic cardiomyopathy (HCM) is an important cardiovascular disease with sudden cardiac death as the most devastating presentation. Implantable cardioverter defibrillators (ICD) are the optimal therapy for prevention of sudden death from ventricular tachycardia or fibrillation of any cause. While there is no controversy with implanting ICDs in patients who have already survived a cardiac arrest, identifying high-risk patients for primary prevention in this disease remains a challenge. Implanting ICDs in patients with HCM is an important clinical consideration since many individuals could achieve normal or near-normal lifespans with this protection.

EPrint Type:Article
Uncontrolled Keywords:Hypertrophic cardiomyopathy; implantable defibrillator; sudden cardiac death
Subjects:Pathological Conditions, Signs and Symptoms > Pathologic Processes > Death
Congenital, Hereditary, and Neonatal Diseases and Abnormalities > Genetic Diseases, Inborn > Cardiomyopathy, Hypertrophic, Familial
Diagnosis > Diagnostic Techniques and Procedures > Diagnostic Techniques, Cardiovascular > Heart Function Tests > Electrocardiography
-Journal Repositories > Indian Pacing and Electrophysiology Journal
Cardiovascular Diseases > Heart Diseases > Arrhythmia
ID Code:140
Deposited By:Indian Pacing and Electrophysiology Journal
Deposited On:02 July 2005

Archive Staff Only: edit this record